Resolute Capital Asset Partners’s ARS Pharmaceuticals SPRY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-140,000	Closed	-$938K	–	46
2023 Q2	$938K	Buy	140,000 +20,000	+17%	+$134K	0.67%	36
2023 Q1	$781K	Buy	+120,000	New	+$781K	0.57%	36